A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction

PHASE2CompletedINTERVENTIONAL
Enrollment

593

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

January 18, 2021

Study Completion Date

January 18, 2021

Conditions
ST Elevation Myocardial Infarction
Interventions
BIOLOGICAL

MEDI6012

MEDI6012

OTHER

Placebo

Placebo

Trial Locations (37)

1122

Research Site, Budapest

1134

Research Site, Budapest

10034

Research Site, Prague

12808

Research Site, Prague

28040

Research Site, Madrid

28046

Research Site, Madrid

36312

Research Site, Pontevedra

40113

Research Site, Ústí nad Labem

46063

Research Site, Liberec

53203

Research Site, Pardubice

65691

Research Site, Brno

91120

Research Site, Jerusalem

197044

Research Site, Saint Petersburg

197706

Research Site, Saint Petersburg

420101

Research Site, Kazan'

3109601

Research Site, Haifa

4941492

Research Site, Petah Tikva

5265601

Research Site, Ramat Gan

6423906

Research Site, Tel Aviv

8410101

Research Site, Beersheba

9103102

Research Site, Jerusalem

30110-934

Research Site, Belo Horizonte

13060-080

Research Site, Campinas

90610-000

Research Site, Porto Alegre

90620-001

Research Site, Porto Alegre

500 05

Research Site, Hradec Králové

1815 JD

Research Site, Alkmaar

6525 GA

Research Site, Nijmegen

6532 SZ

Research Site, Nijmegen

85-094

Research Site, Bydgoszcz

90-549

Research Site, Lodz

91-347

Research Site, Lodz

974 01

Research Site, Banská Bystrica

949 01

Research Site, Nitra

DD1 9SY

Research Site, Dundee

LS13EX

Research Site, Leeds

SG1 4AB

Research Site, Stevenage

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The TIMI Study Group

OTHER

lead

MedImmune LLC

INDUSTRY

NCT03578809 - A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction | Biotech Hunter | Biotech Hunter